BMSN should have some positive movement as soon as they have any results on either the research to develop a new therapeutic solution for traumatic brain injury (TBI) using autologous adipose-derived (fat) stem cells representing a potential cure, or progress in developing a gestational diabetes screening test, as the exclusive licensee granted by UCLA. Progress on either one of these fronts should push the stock to the $1.00 plus range at the very least. Like you though in the present time frame we are all taking a beating. But I believe we will be rewarded SOON.
News 
Market Data 
Discover 
AI
